Printed on: 09/21/2019. Please go to for the most current version of the Policy or related document.
University of Minnisota  Appendix

Services Available from the IND/IDE Regulatory Director

Appendix to Policy

The primary purpose of the IND/IDE services is to promote compliance with FDA regulations in sponsor-investigator drug, device and biologics studies at the University of Minnesota.  Sponsor-Investigators can receive guidance on pre-submission FDA interactions, IND and IDE submissions and associated reports to the FDA and the IRB. 

The following services are available upon request:

  • Offer explanation of IND and IDE regulations
  • Assist in understanding the obligations of a sponsor-investigator
  • Assist in determining product classification, i.e., drug, device, biologic
  • Assist in determining applicability of an IND or IDE
  • Assist in determining contents of IND or IDE
  • Assist in submitting pre-IND/IDE,  IND and IDE applications to FDA
  • Assist in scheduling, coordinating, preparing and attending meetings with FDA
  • Offer regulatory support for IRB applications
  • Offer regulatory assistance during FDA inspections of investigator sponsored clinical trials
  • Circulate periodic news items from FDA relating to sponsor-investigator clinical trials

To receive any of these services contact the IND/IDE Regulatory Director at 612-626 5654 or email the director at

Document Feedback